Online citations, reference lists, and bibliographies.

Measuring The Effects Of CVD Interventions And Studies Across Socioeconomic Groups: A Brief Review.

Emily J Callander, Robyn Mcdermott
Published 2017 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
There is a known socioeconomic skew in prevalence and outcomes of cardiovascular disease (CVD). To document the proportion of clinical trials and observational studies related to CVD recently published in peer-reviewed journals that report the socio-economic distributional differences in their outcomes. We undertook a review of peer-reviewed clinical trials and observational studies relating to CVD published between 01/06/2015-31/12/2015 in PubMed; and identified the proportion that included measures of socioeconomic status and the proportion that stratified results by, or controlled for, socioeconomic status when reporting outcomes. 414 peer reviewed publications reporting the outcomes of clinical trials or observational studies that related to CVD were identified. 32 of these reported on the socioeconomic status of participants. Of these, 20 stratified the results by socioeconomic status or adjusted the results for socioeconomic status. 18 studies measured education attainment, 5 measured income, 1 measured rurality and 1 measured occupation. Of the 414 articles reporting the outcomes of clinical trials or observational studies related to cardiovascular disease in 2015, the effectiveness of the intervention, or the differences in outcomes, between socioeconomic groups was assessed in 5% of studies. This lack of consideration of the effectiveness of trial outcomes or the differences in outcomes across socioeconomic groups impairs the ability of readers, healthcare professionals and policy makers to assess the impact of new treatments or interventions in closing the inequality gap associated with CVD.
This paper references
10.1071/PY16005
Out-of-pocket healthcare expenditure and chronic disease ? do Australians forgo care because of the cost?
Emily J Callander (2016)
10.1016/j.amjcard.2015.04.041
Implementation of the American College of Cardiology/American Heart Association 2008 Guidelines for the Management of Adults With Congenital Heart Disease.
Eva Goossens (2015)
10.1111/1471-0528.13345
Is the probability of prenatal diagnosis or termination of pregnancy different for fetuses with congenital anomalies conceived following assisted reproductive techniques? A population-based evaluation of fetuses with congenital heart defects.
K Tararbit (2015)
10.1016/j.jtcvs.2015.02.016
Adverse cardiac events in children with Williams syndrome undergoing cardiovascular surgery: An analysis of the Society of Thoracic Surgeons Congenital Heart Surgery Database.
Christoph P Hornik (2015)
10.1016/j.ahj.2015.04.007
Worsening heart failure during hospitalization for acute heart failure: Insights from the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF).
Jacob P. Kelly (2015)
10.1016/j.jacc.2015.03.578
Antinuclear Antibodies Are Associated With All-Cause Mortality and Cardiovascular Outcomes in the General Population.
E Blair Solow (2015)
10.1161/CIRCULATIONAHA.114.014522
High-Sensitivity Cardiac Troponin I and B-Type Natriuretic Peptide as Predictors of Vascular Events in Primary Prevention
Brendan M. Everett (2015)
10.1016/j.jacc.2015.06.019
Comprehensive Cardiovascular Risk Factor Control Improves Survival: The BARI 2D Trial.
Vera A. Bittner (2015)
10.1016/0140-6736(91)93068-K
Health inequalities among British civil servants: the Whitehall II study
Michael Marmot (1991)
10.1056/NEJMx150029
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
Jennifer B Green (2015)
10.1161/HYPERTENSIONAHA.115.05342
Endotoxin and &bgr;-1,3-D-Glucan in Concentrated Ambient Particles Induce Rapid Increase in Blood Pressure in Controlled Human Exposures
Jia Zhong (2015)
10.1073/pnas.162086599
Can patient self-management help explain the SES health gradient?
Dana P. Goldman (2002)
Occupation
L. E. Hinkle (1968)
10.1016/j.amjcard.2015.04.052
Relation of Acute Heart Failure Hospital Length of Stay to Subsequent Readmission and All-Cause Mortality.
Kristi Reynolds (2015)
10.1126/science.161.3838.238
Occupation, education, and coronary heart disease. Risk is influenced more by education and background than by occupational experiences, in the Bell System.
Lawrence E. Hinkle (1968)
10.1210/JC.2015-1367
Dysglycemia and Cognitive Dysfunction and Ill Health in People With High CV Risk: Results From the ONTARGET/TRANSCEND Studies.
Tali Cukierman-Yaffe (2015)
10.1136/heartjnl-2014-307015
Higher circulating adiponectin levels are associated with increased risk of atrial fibrillation in older adults
Fima Macheret (2015)
10.1093/gerona/glv027
Greater Skeletal Muscle Fat Infiltration Is Associated With Higher All-Cause and Cardiovascular Mortality in Older Men.
Iva Miljkovic (2015)
10.1016/j.clinthera.2008.11.012
Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel.
Gabriel Chodick (2008)
10.1016/B978-0-12-384931-1.00018-0
R
J. M. Lackie (2013)
10.1093/acprof:oso/9780198525738.003.0001
Coronary heart disease epidemiology : from aetiology to public health
Michael Marmot (1992)
10.1016/j.amjcard.2015.03.060
Leukocyte telomere length and coronary artery calcium.
Steven C. Hunt (2015)
10.1111/j.1464-5491.2010.03133.x
Factors associated with medication adherence to oral hypoglycaemic agents in different ethnic groups suffering from type 2 diabetes: a systematic literature review and suggestions for further research.
Benedict Peeters (2011)
10.1161/CIRCIMAGING.114.002846
Relationship Between Alcohol Consumption and Cardiac Structure and Function in the Elderly: The Atherosclerosis Risk in Communities Study
Alexandra Gonçalves (2015)
10.1210/jc.2015-1917
Adipose Tissue Redistribution and Ectopic Lipid Deposition in Active Acromegaly and Effects of Surgical Treatment.
Carlos M. Reyes-Vidal (2015)
10.1164/ajrccm.157.6.9712007
Adherence with twice-daily dosing of inhaled steroids. Socioeconomic and health-belief differences.
Andrea J. Apter (1998)
10.1053/j.ajkd.2015.02.339
Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study.
Wolfgang C. Winkelmayer (2015)
10.1080/00325481.2015.1064300
Vaccination Serology Status and Cardiovascular Mortality: Insight from NHANES III and Continuous NHANES
Ankit Chothani (2015)
Us mortality by economic
P. D. Sorlie (1995)
10.1016/S0140-6736(00)04337-3
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials
David Moher (2001)
10.1136/hrt.45.1.13
Social class and coronary heart disease.
Gm Rose (1981)
10.1136/heartjnl-2014-307043
Heart rate is associated with progression of atrial fibrillation, independent of rhythm
Fredrik Holmqvist (2015)
10.1016/j.socscimed.2004.04.026
Are racial disparities in health conditional on socioeconomic status?
Melissa Farmer (2005)
10.2307/j.ctvrnfqk1.10
? ? ? ? f ? ? ? ? ?
A ADoefaa (2003)
Out-of-Pocket Costs: Hitting the Most Vulnerable Hardest
S. Duckett (2014)
10.1001/jama.2015.8881
Effects of Testosterone Administration for 3 Years on Subclinical Atherosclerosis Progression in Older Men With Low or Low-Normal Testosterone Levels: A Randomized Clinical Trial.
Shehzad Basaria (2015)
10.13016/mm3g-bslp
Constructing the evidence base on the social determinants of health: A guide
Josiane Bonnefoy (2007)
10.1016/j.amjcard.2015.05.035
Predictors and Outcomes of Routine Versus Optimal Medical Therapy in Stable Coronary Heart Disease.
Soohun Chun (2015)
10.1136/bmj.h3786
Real world effectiveness of warfarin among ischemic stroke patients with atrial fibrillation: observational analysis from Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) study
Ying Xian (2015)
10.1016/j.amjmed.2015.02.025
Outcomes of acute myocardial infarction in patients with hypertrophic cardiomyopathy.
Tanush Gupta (2015)
10.1111/trf.13046
Plasma exchange effectively removes 52- and 60-kDa anti-Ro/SSA and anti-La/SSB antibodies in pregnant women with congenital heart block.
Marta Tonello (2015)
10.1146/annurev.pu.08.050187.000551
Social/economic status and disease.
Michael Marmot (1987)
10.1016/j.ahj.2015.04.017
Six-year change in high-sensitivity C-reactive protein and risk of diabetes, cardiovascular disease, and mortality.
Christina M. Parrinello (2015)
10.1097/AOG.0000000000000919
Lactation Duration and Midlife Atherosclerosis
Erica P Gunderson (2015)
10.1161/CIRCHEARTFAILURE.114.001996
Evaluation of the Incremental Prognostic Utility of Increasingly Complex Testing in Chronic Heart Failure
Tariq Ahmad (2015)
10.1016/j.ahj.2015.04.020
New-onset versus prior history of atrial fibrillation: Outcomes from the AFFIRM trial.
Abdulla A Damluji (2015)
Analysis of associations between CVD risk factors and socioeconomic factors over time
G. Danaei (2013)
10.1001/jama.285.15.1987
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.
David Moher (2001)
10.5694/MJA12.11638
Can't escape it: the out-of-pocket cost of health care in Australia.
Farhat Yusuf (2013)
10.1186/1471-2458-11-684
Socioeconomic status and race/ethnicity independently predict health decline among older diabetics
Emily J Nicklett (2011)
Associ - ations of metabolic syndrome and its components with mortality in the elderly : a cohort study of 73 , 547 Taiwanese adults
H. Y. Hu
10.1161/01.CIR.88.4.1973
Socioeconomic factors and cardiovascular disease: a review of the literature.
George A. Kaplan (1993)
10.1681/ASN.2014040414
Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis: The EVOLVE Trial.
Sharon M Moe (2015)
10.1089/heat.2017.29040.rtl
The Social Determinants of Health
F ChenAntonia (2017)
10.1097/MD.0000000000000956
Associations of Metabolic Syndrome and its Components With Mortality in the Elderly
Yung-Feng Yen (2015)
10.1515/9783111576855-015
J
Seguin Hen (1824)
10.1016/j.pnpbp.2015.01.009
Evaluation of the dopamine β-hydroxylase (DβH) inhibitor nepicastat in participants who meet criteria for cocaine use disorder
Richard De La Garza (2015)
10.1136/bmj.h3234
Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18 168 people with type 1 diabetes: observational study
Isabelle I K Steineck (2015)
10.1161/CIRCHEARTFAILURE.114.001885
Risk of Heart Failure and Death After Prolonged Smoking CessationCLINICAL PERSPECTIVE
Amiya A. Ahmed (2015)
10.1177/0003319714549557
Relationship Between Alcohol Consumption and Serum Lipid Profiles Among Middle-Aged Population in China
G Hao (2015)
10.1016/j.jacc.2015.05.054
Glycemic Control in Type 1 Diabetes and Long-Term Risk of Cardiovascular Events or Death After Coronary Artery Bypass Grafting.
Thomas Nyström (2015)
10.1001/jama.2015.10082
Association Between Blood Pressure Control and Risk of Recurrent Intracerebral Hemorrhage.
Alessandro Biffi (2015)
10.1016/S0735-1097(14)62045-3
ASSOCIATION OF DUAL ANTIPLATELET THERAPY WITH REDUCED MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH SYMPTOMATIC PERIPHERAL ARTERIAL DISEASE
Ehrin J Armstrong (2014)
10.1016/j.amjmed.2015.01.022
Thirty-day Hospital Readmissions in Patients with Non-ST-segment Elevation Acute Myocardial Infarction.
Mayra S Tisminetzky (2015)
10.3945/ajcn.114.106435
Higher usual alcohol consumption was associated with a lower 41-y mortality risk from coronary artery disease in men independent of genetic and common environmental factors: the prospective NHLBI Twin Study.
Jun Dai (2015)
10.1161/CIRCULATIONAHA.114.014992
Association of Discharge Aspirin Dose With Outcomes After Acute Myocardial Infarction: Insights From the Treatment with ADP Receptor Inhibitors Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) Study
Ying Xian (2015)
Distribution of Expediture on Health Goods and Services by Australian Households
Laurie Brown (2008)
10.1016/j.amjcard.2015.03.018
Ability of Reduced Lung Function to Predict Development of Atrial Fibrillation in Persons Aged 45 to 84 Years (from the Multi-Ethnic Study of Atherosclerosis-Lung Study).
Harjit Chahal (2015)
10.1001/jamainternmed.2015.1668
Mediterranean Diet and Age-Related Cognitive Decline: A Randomized Clinical Trial.
Cinta Valls-Pedret (2015)
10.1161/STROKEAHA.115.009592
Systolic Blood Pressure Control and Mortality After Stroke in Hypertensive Patients
Peter M. Okin (2015)
10.1016/j.ahj.2015.05.004
Cardiovascular mortality prediction in veterans with arm exercise vs pharmacologic myocardial perfusion imaging.
Wade H. Martin (2015)
10.1111/jgs.13533
Effect of Nurse-Implemented Transitional Care for Chinese Individuals with Chronic Heart Failure in Hong Kong: A Randomized Controlled Trial.
Doris Sau-Fung Yu (2015)
10.1016/j.amjcard.2015.05.009
Chocolate Consumption and Risk of Atrial Fibrillation (from the Physicians' Health Study).
Owais Khawaja (2015)
10.1161/ATVBAHA.115.305945
Fibroblast Growth Factor 23 Is Associated With Carotid Plaque Presence and Area: The Northern Manhattan Study
Nirav H. Shah (2015)
Aortic stiffness
P. I. Georgianos (2015)
10.1016/j.ahj.2015.03.004
Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODYSSEY COMBO I study.
Dean J Kereiakes (2015)
10.1007/s00277-014-2291-x
A 5-year follow-up in deferasirox treatment: improvement of cardiac and hepatic iron overload and amelioration in cardiac function in thalassemia major patients
Elena Cassinerio (2014)
10.1097/MD.0000000000000852
Risk Factors and Consequences of Cortical Thickness in an Asian Population
Saima Hilal (2015)
10.1016/j.amjmed.2014.12.020
Substantial Discrepancy Between Fluid and Weight Loss During Acute Decompensated Heart Failure Treatment.
Jeffrey M. Testani (2015)
10.1161/01.CIR.94.9.2041
Conference on Socioeconomic Status and Cardiovascular Health and disease.
Claude Lenfant (1996)
10.3121/cmr.2013.1113
Patient Characteristics Associated with Medication Adherence
Sharon J. Rolnick (2013)
10.1515/9783111548050-024
M
M. Sankar (1824)
[Insulin pump therapy].
Eero Helve (1988)
10.1515/9783111413426-013
L
Il Liceo (1824)
10.1016/j.jacc.2015.03.544
Fasting triglycerides predict recurrent ischemic events in patients with acute coronary syndrome treated with statins.
Gregory G Schwartz (2015)
10.1093/intqhc/mzm011
Socioeconomic disadvantage and primary non-adherence with medication in Sweden.
Sarah P. Wamala (2007)
10.7326/M14-2948
Coronary Computed Tomography Angiography Versus Radionuclide Myocardial Perfusion Imaging in Patients With Chest Pain Admitted to Telemetry
Jeffrey M. Levsky (2015)
10.1016/j.amjcard.2015.05.014
Usefulness of B-type Natriuretic Peptides to Predict Cardiovascular Events in Women (from the Women's Health Study).
Brendan M. Everett (2015)
10.1515/9783111438443-006
N
Città DI Torino (1824)
10.1001/jama.2015.10945
Effect of Lifestyle-Focused Text Messaging on Risk Factor Modification in Patients With Coronary Heart Disease: A Randomized Clinical Trial.
Clara K Chow (2015)
10.1016/j.ahj.2015.03.015
Ticagrelor versus clopidogrel in Asian patients with acute coronary syndrome: A retrospective analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial.
Hyun-Jae Kang (2015)
10.1148/radiol.15142062
Association of Coronary Artery Calcification and Mortality in the National Lung Screening Trial: A Comparison of Three Scoring Methods.
Caroline Chiles (2015)
10.1097/MLR.0000000000000378
A Randomized Trial of Mobile Health Support for Heart Failure Patients and Their Informal Caregivers: Impacts on Caregiver-reported Outcomes
John D. Piette (2015)
10.1161/ATVBAHA.115.305765
Low Impact of Traditional Risk Factors on Carotid Intima-Media Thickness: The ELSA-Brasil Cohort
Itamar de Souza Santos (2015)
10.1016/b978-0-12-384931-1.00003-9
C
J. M. Lackie (2013)
10.1161/CIRCRESAHA.115.306332
A Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients With Ischemic or Nonischemic Heart Failure.
Emerson C. Perin (2015)
10.1111/jgs.13482
Metabolic Burden and Disease and Mortality Risk Associated with Impaired Fasting Glucose in Elderly Adults.
Katherine Samaras (2015)
10.1016/j.ahj.2015.04.028
Intermediate and long-term risk of new-onset heart failure after hospitalization for pneumonia in elderly adults.
Vicente F Corrales-Medina (2015)
10.1016/j.jacc.2015.03.003
Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction.
Robert W Yeh (2015)
10.1016/j.ahj.2015.04.006
Predictors of clinical outcomes in acute decompensated heart failure: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure outcome models.
Prateeti Khazanie (2015)
10.1161/CIRCULATIONAHA.115.015884
Prognostic Importance of Impaired Systolic Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone
Amil M Shah (2015)
10.1016/j.cjca.2015.02.020
CHA2DS2-VAS(C) and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation.
Taya V. Glotzer (2015)
10.1016/j.ahj.2015.05.008
Race and ethnicity influences on cardiovascular and renal events in patients with diabetes mellitus.
Eldrin F. Lewis (2015)
10.1161/CIRCHEARTFAILURE.114.001885
Risk of Heart Failure and Death After Prolonged Smoking Cessation: Role of Amount and Duration of Prior Smoking
Amiya A. Ahmed (2015)
10.1016/j.ahj.2015.05.007
The association of in-hospital guideline adherence and longitudinal postdischarge mortality in older patients with non-ST-segment elevation myocardial infarction.
Bimal R. Shah (2015)
10.1016/j.ahj.2015.04.027
Trends in mortality and recurrent coronary heart disease events after an acute myocardial infarction among Medicare beneficiaries, 2001-2009.
Todd M. Brown (2015)
10.1093/ije/30.6.1397
Income differences in mortality: a register-based follow-up study of three million men and women.
Pekka T Martikainen (2001)
10.1161/CIRCULATIONAHA.115.015464
Randomized Trial of the Effect of Pharmacist Prescribing on Improving Blood Pressure in the Community: The Alberta Clinical Trial in Optimizing Hypertension (RxACTION)
Ross Tsuyuki (2015)
10.1016/S0140-6736(14)62115-2
Anacetrapib as lipid-modifying therapy in patients with heterozygous familial hypercholesterolaemia (REALIZE): a randomised, double-blind, placebo-controlled, phase 3 study
John J. P. Kastelein (2015)
10.1016/S0140-6736(15)60158-1
Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial
G. K. Hovingh (2015)
10.2307/3343231
Epidemiology and Prevention of Cardiovascular Diseases: A Global Challenge
Lewis H. Kuller (1998)
10.1136/jech-2013-203053
Socioeconomic disadvantage and disease-specific mortality in Asia: systematic review with meta-analysis of population-based cohort studies
Prin Vathesatogkit (2014)
10.1186/1471-2458-11-S6-S8
A dose-response relationship between exposure to a large-scale HIV preventive intervention and consistent condom use with different sexual partners of female sex workers in southern India
Kathleen Deering (2011)
10.1097/NNR.0000000000000102
Home-Based Exercise in Older Adults Recently Discharged From the Hospital for Cardiovascular Disease in China: Randomized Clinical Trial
Xueyu Li (2015)
10.1016/j.amjmed.2014.11.034
The complex relationship of race to outcomes in heart failure with preserved ejection fraction.
Jerry H. Gurwitz (2015)
10.1161/STROKEAHA.113.002414
Under-Reporting of Socioeconomic Status of Patients in Stroke Trials: Adherence to Consort Principles
Parker J Magin (2013)
10.3945/ajcn.114.103028
Supplementation with a blend of krill and salmon oil is associated with increased metabolic risk in overweight men.
Benjamin B Albert (2015)
10.1161/CIRCULATIONAHA.114.014335
Coronary Artery Bypass Grafting in Patients 50 Years or Younger: A Swedish Nationwide Cohort Study
Magnus Dalén (2015)
10.1353/hpu.0.0259
Disparities in Adherence to Hypertensive Care in Urban Ambulatory Settings
Chima D Ndumele (2010)
10.1053/j.ajkd.2015.02.324
Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
David M. Charytan (2015)
10.1053/j.ajkd.2015.01.018
Aortic Stiffness, Ambulatory Blood Pressure, and Predictors of Response to Antihypertensive Therapy in Hemodialysis.
Panagiotis I Georgianos (2015)
10.1016/j.jacc.2015.05.057
Changes in Follow-Up Left Ventricular Ejection Fraction Associated With Outcomes in Primary Prevention Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Recipients.
Yiyi Zhang (2015)
10.1016/j.athoracsur.2015.02.054
Pericardiectomy for Constrictive Pericarditis: 20 Years of Experience at the Montreal Heart Institute.
Nicola Vistarini (2015)
trials adherence to consort principles
K. F. Ferraro Farmer
10.1016/j.jacc.2015.06.1309
Clinical Outcomes for Peripartum Cardiomyopathy in North America: Results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy).
Dennis M. McNamara (2015)
10.1016/j.ahj.2015.05.003
Diuretic response in acute heart failure-an analysis from ASCEND-HF.
Jozine M. ter Maaten (2015)
Understanding associations among race
D. R. Williams (2016)
10.1161/STROKEAHA.115.009087
Antithrombotic Treatment Following Intracerebral Hemorrhage in Patients With and Without Atrial Fibrillation
Johanna Pennlert (2015)
10.1037/hea0000242
Understanding associations among race, socioeconomic status, and health: Patterns and prospects.
David R. Williams (2016)
10.2105/AJPH.85.7.949
US mortality by economic, demographic, and social characteristics: the National Longitudinal Mortality Study.
Paul D. Sorlie (1995)
10.1161/CIRCULATIONAHA.113.001470
The Global Cardiovascular Risk Transition: Associations of Four Metabolic Risk Factors with National Income, Urbanization, and Western Diet in 1980 and 2008
Goodarz Danaei (2013)
10.1161/CIRCHEARTFAILURE.115.002097
Kansas City Cardiomyopathy Questionnaire Score Is Associated With Incident Heart Failure Hospitalization in Patients With Chronic Kidney Disease Without Previously Diagnosed Heart Failure: Chronic Renal Insufficiency Cohort Study
Rakesh K Mishra (2015)
10.5414/CN108494
Association of carotid intima-media thickness with cardiovascular risk factors and patient outcomes in advanced chronic kidney disease: the RRI-CKD study
Alan L. Hinderliter (2015)
10.1016/j.amjcard.2015.06.016
Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin.
Siqin Ye (2015)
10.1016/j.jacc.2015.06.1089
Temporal Trends and Factors Associated With Cardiac Rehabilitation Referral Among Patients Hospitalized With Heart Failure: Findings From Get With The Guidelines-Heart Failure Registry.
Harsh B Golwala (2015)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar